 | • レポートコード：D0GIR-02186 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：New Technology |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、新型コロナウイルス感染症RNAワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。新型コロナウイルス感染症RNAワクチンの種類別市場規模（開発中、前臨床、臨床I、臨床II）、用途別市場規模（製薬・バイオテクノロジー企業、病院、学術・研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：MODERNA、BioNTech、CureVac、Zydus Cadila、Stermirna ・地域別グローバル市場分析 2015年-2020年 ・新型コロナウイルス感染症RNAワクチンの北米市場（アメリカ、カナダ、メキシコ） ・新型コロナウイルス感染症RNAワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新型コロナウイルス感染症RNAワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新型コロナウイルス感染症RNAワクチンの南米市場（ブラジル、アルゼンチン） ・新型コロナウイルス感染症RNAワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：開発中、前臨床、臨床I、臨床II ・用途別分析：製薬・バイオテクノロジー企業、病院、学術・研究機関、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The COVID-19 RNA Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global COVID-19 RNA Vaccine sales will be xx in 2020 from COVID-19 RNA Vaccine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global COVID-19 RNA Vaccine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the COVID-19 RNA Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on COVID-19 RNA Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
COVID-19 RNA Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, COVID-19 RNA Vaccine market has been segmented into:
Being Developed
Preclinical
Clinical I
Clinical II
By Application, COVID-19 RNA Vaccine has been segmented into:
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global COVID-19 RNA Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level COVID-19 RNA Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global COVID-19 RNA Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the COVID-19 RNA Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and COVID-19 RNA Vaccine Market Share Analysis
COVID-19 RNA Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, COVID-19 RNA Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the COVID-19 RNA Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in COVID-19 RNA Vaccine are:
MODERNA
BioNTech
CureVac
Zydus Cadila
Stermirna
Among other players domestic and global, COVID-19 RNA Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 COVID-19 RNA Vaccine Market Overview
1.1 Product Overview and Scope of COVID-19 RNA Vaccine
1.2 Classification of COVID-19 RNA Vaccine by Type
1.2.1 Global COVID-19 RNA Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global COVID-19 RNA Vaccine Revenue Market Share by Type in 2019
1.2.3 Being Developed
1.2.4 Preclinical
1.2.5 Clinical I
1.2.6 Clinical II
1.3 Global COVID-19 RNA Vaccine Market by Application
1.3.1 Overview: Global COVID-19 RNA Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical And Biotechnology Companies
1.3.3 Hospital
1.3.4 Academic And Research Organizations
1.3.5 Other
1.4 Global COVID-19 RNA Vaccine Market by Regions
1.4.1 Global COVID-19 RNA Vaccine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of COVID-19 RNA Vaccine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) COVID-19 RNA Vaccine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) COVID-19 RNA Vaccine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COVID-19 RNA Vaccine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) COVID-19 RNA Vaccine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COVID-19 RNA Vaccine Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: COVID-19 RNA Vaccine Industry Impact
1.5.1 COVID-19 Potential Implications for the COVID-19 RNA Vaccine
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on COVID-19 RNA Vaccine
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 MODERNA
2.1.1 MODERNA Details
2.1.2 MODERNA Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 MODERNA SWOT Analysis
2.1.4 MODERNA Product and Services
2.1.5 MODERNA COVID-19 RNA Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioNTech
2.2.1 BioNTech Details
2.2.2 BioNTech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BioNTech SWOT Analysis
2.2.4 BioNTech Product and Services
2.2.5 BioNTech COVID-19 RNA Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.3 CureVac
2.3.1 CureVac Details
2.3.2 CureVac Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CureVac SWOT Analysis
2.3.4 CureVac Product and Services
2.3.5 CureVac COVID-19 RNA Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.4 Zydus Cadila
2.4.1 Zydus Cadila Details
2.4.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Zydus Cadila SWOT Analysis
2.4.4 Zydus Cadila Product and Services
2.4.5 Zydus Cadila COVID-19 RNA Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.5 Stermirna
2.5.1 Stermirna Details
2.5.2 Stermirna Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Stermirna SWOT Analysis
2.5.4 Stermirna Product and Services
2.5.5 Stermirna COVID-19 RNA Vaccine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global COVID-19 RNA Vaccine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 COVID-19 RNA Vaccine Players Market Share
3.2.2 Top 10 COVID-19 RNA Vaccine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global COVID-19 RNA Vaccine Revenue and Market Share by Regions
4.2 North America COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
4.3 Europe COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
4.5 South America COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
5 North America COVID-19 RNA Vaccine Revenue by Countries
5.1 North America COVID-19 RNA Vaccine Revenue by Countries (2015-2020)
5.2 USA COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
5.3 Canada COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
5.4 Mexico COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
6 Europe COVID-19 RNA Vaccine Revenue by Countries
6.1 Europe COVID-19 RNA Vaccine Revenue by Countries (2015-2020)
6.2 Germany COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
6.3 UK COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
6.4 France COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
6.5 Russia COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
6.6 Italy COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific COVID-19 RNA Vaccine Revenue by Countries
7.1 Asia-Pacific COVID-19 RNA Vaccine Revenue by Countries (2015-2020)
7.2 China COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
7.3 Japan COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
7.4 Korea COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
7.5 India COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
8 South America COVID-19 RNA Vaccine Revenue by Countries
8.1 South America COVID-19 RNA Vaccine Revenue by Countries (2015-2020)
8.2 Brazil COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
8.3 Argentina COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue COVID-19 RNA Vaccine by Countries
9.1 Middle East & Africa COVID-19 RNA Vaccine Revenue by Countries (2015-2020)
9.2 Saudi Arabia COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
9.3 UAE COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
9.4 Egypt COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
9.5 South Africa COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global COVID-19 RNA Vaccine Revenue and Market Share by Type (2015-2020)
10.2 Global COVID-19 RNA Vaccine Market Forecast by Type (2019-2024)
10.3 Being Developed Revenue Growth Rate (2015-2025)
10.4 Preclinical Revenue Growth Rate (2015-2025)
10.5 Clinical I Revenue Growth Rate (2015-2025)
10.6 Clinical II Revenue Growth Rate (2015-2025)
11 Global COVID-19 RNA Vaccine Market Segment by Application
11.1 Global COVID-19 RNA Vaccine Revenue Market Share by Application (2015-2020)
11.2 COVID-19 RNA Vaccine Market Forecast by Application (2019-2024)
11.3 Pharmaceutical And Biotechnology Companies Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
11.5 Academic And Research Organizations Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global COVID-19 RNA Vaccine Market Size Forecast (2021-2025)
12.1 Global COVID-19 RNA Vaccine Market Size Forecast (2021-2025)
12.2 Global COVID-19 RNA Vaccine Market Forecast by Regions (2021-2025)
12.3 North America COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
12.4 Europe COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
12.6 South America COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global COVID-19 RNA Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of COVID-19 RNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global COVID-19 RNA Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market COVID-19 RNA Vaccine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global COVID-19 RNA Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. MODERNA Corporate Information, Location and Competitors
Table 7. MODERNA COVID-19 RNA Vaccine Major Business
Table 8. MODERNA COVID-19 RNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 9. MODERNA SWOT Analysis
Table 10. MODERNA COVID-19 RNA Vaccine Product and Solutions
Table 11. MODERNA COVID-19 RNA Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. BioNTech Corporate Information, Location and Competitors
Table 13. BioNTech COVID-19 RNA Vaccine Major Business
Table 14. BioNTech COVID-19 RNA Vaccine Total Revenue (USD Million) (2018-2019)
Table 15. BioNTech SWOT Analysis
Table 16. BioNTech COVID-19 RNA Vaccine Product and Solutions
Table 17. BioNTech COVID-19 RNA Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. CureVac Corporate Information, Location and Competitors
Table 19. CureVac COVID-19 RNA Vaccine Major Business
Table 20. CureVac COVID-19 RNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 21. CureVac SWOT Analysis
Table 22. CureVac COVID-19 RNA Vaccine Product and Solutions
Table 23. CureVac COVID-19 RNA Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Zydus Cadila Corporate Information, Location and Competitors
Table 25. Zydus Cadila COVID-19 RNA Vaccine Major Business
Table 26. Zydus Cadila COVID-19 RNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 27. Zydus Cadila SWOT Analysis
Table 28. Zydus Cadila COVID-19 RNA Vaccine Product and Solutions
Table 29. Zydus Cadila COVID-19 RNA Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Stermirna Corporate Information, Location and Competitors
Table 31. Stermirna COVID-19 RNA Vaccine Major Business
Table 32. Stermirna COVID-19 RNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 33. Stermirna SWOT Analysis
Table 34. Stermirna COVID-19 RNA Vaccine Product and Solutions
Table 35. Stermirna COVID-19 RNA Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Global COVID-19 RNA Vaccine Revenue (Million USD) by Players (2015-2020)
Table 37. Global COVID-19 RNA Vaccine Revenue Share by Players (2015-2020)
Table 38. Global COVID-19 RNA Vaccine Revenue (Million USD) by Regions (2015-2020)
Table 39. Global COVID-19 RNA Vaccine Revenue Market Share by Regions (2015-2020)
Table 40. North America COVID-19 RNA Vaccine Revenue by Countries (2015-2020)
Table 41. North America COVID-19 RNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 42. Europe COVID-19 RNA Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 43. Asia-Pacific COVID-19 RNA Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 44. South America COVID-19 RNA Vaccine Revenue by Countries (2015-2020)
Table 45. South America COVID-19 RNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 46. Middle East and Africa COVID-19 RNA Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 47. Middle East and Africa COVID-19 RNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 48. Global COVID-19 RNA Vaccine Revenue (Million USD) by Type (2015-2020)
Table 49. Global COVID-19 RNA Vaccine Revenue Share by Type (2015-2020)
Table 50. Global COVID-19 RNA Vaccine Revenue Forecast by Type (2021-2025)
Table 51. Global COVID-19 RNA Vaccine Revenue by Application (2015-2020)
Table 52. Global COVID-19 RNA Vaccine Revenue Share by Application (2015-2020)
Table 53. Global COVID-19 RNA Vaccine Revenue Forecast by Application (2021-2025)
Table 54. Global COVID-19 RNA Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. COVID-19 RNA Vaccine Picture
Figure 2. Global COVID-19 RNA Vaccine Revenue Market Share by Type in 2019
Figure 3. Being Developed Picture
Figure 4. Preclinical Picture
Figure 5. Clinical I Picture
Figure 6. Clinical II Picture
Figure 7. COVID-19 RNA Vaccine Revenue Market Share by Application in 2019
Figure 8. Pharmaceutical And Biotechnology Companies Picture
Figure 9. Hospital Picture
Figure 10. Academic And Research Organizations Picture
Figure 11. Other Picture
Figure 12. Global COVID-19 RNA Vaccine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America COVID-19 RNA Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe COVID-19 RNA Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific COVID-19 RNA Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America COVID-19 RNA Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa COVID-19 RNA Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global COVID-19 RNA Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global COVID-19 RNA Vaccine Revenue Share by Players in 2019
Figure 20. Global Top 5 Players COVID-19 RNA Vaccine Revenue Market Share in 2019
Figure 21. Global Top 10 Players COVID-19 RNA Vaccine Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global COVID-19 RNA Vaccine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global COVID-19 RNA Vaccine Revenue Market Share by Regions (2015-2020)
Figure 25. Global COVID-19 RNA Vaccine Revenue Market Share by Regions in 2018
Figure 26. North America COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 27. Europe COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 29. South America COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 31. North America COVID-19 RNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 32. North America COVID-19 RNA Vaccine Revenue Market Share by Countries in 2019
Figure 33. USA COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 34. Canada COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 35. Mexico COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 36. Europe COVID-19 RNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 37. Europe COVID-19 RNA Vaccine Revenue Market Share by Countries in 2019
Figure 38. Germany COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 39. UK COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 40. France COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 41. Russia COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 42. Italy COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific COVID-19 RNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific COVID-19 RNA Vaccine Revenue Market Share by Countries in 2019
Figure 45. China COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 46. Japan COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 47. Korea COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 48. India COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 50. South America COVID-19 RNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 51. South America COVID-19 RNA Vaccine Revenue Market Share by Countries in 2019
Figure 52. Brazil COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 53. Argentina COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa COVID-19 RNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa COVID-19 RNA Vaccine Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 57. UAE COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 58. Egypt COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 59. South Africa COVID-19 RNA Vaccine Revenue and Growth Rate (2015-2020)
Figure 60. Global COVID-19 RNA Vaccine Revenue Share by Type (2015-2020)
Figure 61. Global COVID-19 RNA Vaccine Revenue Share by Type in 2019
Figure 62. Global COVID-19 RNA Vaccine Market Share Forecast by Type (2021-2025)
Figure 63. Global Being Developed Revenue Growth Rate (2015-2020)
Figure 64. Global Preclinical Revenue Growth Rate (2015-2020)
Figure 65. Global Clinical I Revenue Growth Rate (2015-2020)
Figure 66. Global Clinical II Revenue Growth Rate (2015-2020)
Figure 67. Global COVID-19 RNA Vaccine Revenue Share by Application (2015-2020)
Figure 68. Global COVID-19 RNA Vaccine Revenue Share by Application in 2019
Figure 69. Global COVID-19 RNA Vaccine Market Share Forecast by Application (2021-2025)
Figure 70. Global Pharmaceutical And Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Academic And Research Organizations Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global COVID-19 RNA Vaccine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global COVID-19 RNA Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global COVID-19 RNA Vaccine Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
Figure 78. Europe COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
Figure 80. South America COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa COVID-19 RNA Vaccine Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
新型コロナウイルス感染症DNAワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 DNA Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 新型コロナウイルス感染症組換えタンパク質ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 Recombinant Protein Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- アデノウイルスベクターワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Adenovirus Vector Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- インフルエンザウイルスベクターワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Influenza Virus Vector Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- エボラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Ebola Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…